Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Prestige Consumer Healthcare (PBH) Change in Inventory (2016 - 2025)

Historic Change in Inventory for Prestige Consumer Healthcare (PBH) over the last 16 years, with Q4 2025 value amounting to -$3.2 million.

  • Prestige Consumer Healthcare's Change in Inventory fell 395.33% to -$3.2 million in Q4 2025 from the same period last year, while for Dec 2025 it was $3.0 million, marking a year-over-year increase of 957.6%. This contributed to the annual value of $9.3 million for FY2025, which is 13811.12% up from last year.
  • Latest data reveals that Prestige Consumer Healthcare reported Change in Inventory of -$3.2 million as of Q4 2025, which was down 395.33% from $5.8 million recorded in Q3 2025.
  • Prestige Consumer Healthcare's Change in Inventory's 5-year high stood at $16.8 million during Q4 2022, with a 5-year trough of -$13.6 million in Q4 2023.
  • Its 5-year average for Change in Inventory is $1.6 million, with a median of $875500.0 in 2021.
  • Per our database at Business Quant, Prestige Consumer Healthcare's Change in Inventory tumbled by 1830000.0% in 2021 and then soared by 110340.91% in 2022.
  • Over the past 5 years, Prestige Consumer Healthcare's Change in Inventory (Quarter) stood at -$1.7 million in 2021, then soared by 1103.41% to $16.8 million in 2022, then tumbled by 180.87% to -$13.6 million in 2023, then skyrocketed by 77.25% to -$3.1 million in 2024, then dropped by 3.95% to -$3.2 million in 2025.
  • Its last three reported values are -$3.2 million in Q4 2025, $5.8 million for Q3 2025, and $4.4 million during Q2 2025.